BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 36342796)

  • 1. 68Ga-DOTA-FAPI-04 PET/CT Imaging in a Case of Radioactive Iodine-Induced Chronic Parotitis.
    Xu T; Zhang Y; Wu R; Ding H; Chen Y
    Clin Nucl Med; 2022 Dec; 47(12):1082-1083. PubMed ID: 36342796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral Chronic Parotitis With 68 Ga-DOTA-FAPI-04 PET/CT and 18 F-FDG PET/CT Imaging in a Case of a Patient With Papillary Thyroid Carcinoma.
    Roshanravan V; Sadeghi R; Zakavi SR; Norouzbeigi N; Aghaee A
    Clin Nucl Med; 2023 Dec; 48(12):e577-e579. PubMed ID: 37756475
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Chen Y; Zheng S; Zhang J; Yao S; Miao W
    Ann Nucl Med; 2022 Jul; 36(7):610-622. PubMed ID: 35551610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-FAPI PET/CT in Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy.
    Fu H; Fu J; Huang J; Su X; Chen H
    Clin Nucl Med; 2021 May; 46(5):427-430. PubMed ID: 33661204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleural Metastasis of Papillary Thyroid Cancer Depicted by 68Ga-FAPI PET/CT.
    Chen Y; Zheng S; Zhang J; Yao S; Miao W
    Clin Nucl Med; 2022 May; 47(5):467-468. PubMed ID: 35025798
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
    Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
    [No Abstract]   [Full Text] [Related]  

  • 7. Follicular Thyroid Adenoma Showing Avid Uptake on 68Ga-DOTA-FAPI-04 PET/CT.
    Ou L; Wu J; Wu J; Mou C; Zhang C
    Clin Nucl Med; 2021 Oct; 46(10):840-841. PubMed ID: 34172606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution, pharmacokinetics, dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron Emission Tomography/Computed Tomography in Thyroid Cancer.
    Bal C; Chakraborty D; Khan D
    PET Clin; 2022 Apr; 17(2):265-283. PubMed ID: 35256297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.
    Nabaa B; Takahashi K; Sasaki T; Okizaki A; Aburano T
    AJNR Am J Neuroradiol; 2012 Nov; 33(10):1964-70. PubMed ID: 22555571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-DOTA-FAPI-04 Uptake of Accessory Breast in a Patient With Breast Cancer.
    Xu T; Wang W; Yang C; Cai L; Chen Y
    Clin Nucl Med; 2022 Jun; 47(6):564-565. PubMed ID: 35081060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAP-Targeted Radionuclide Therapy of Advanced Radioiodine-Refractory Differentiated Thyroid Cancer With Multiple Cycles of 177 Lu-FAPI-46.
    Fu H; Huang J; Sun L; Wu H; Chen H
    Clin Nucl Med; 2022 Oct; 47(10):906-907. PubMed ID: 35485857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 68Ga-DOTA-FAPI-04 PET/CT Imaging in a Case of SAPHO Syndrome.
    Xu T; Huang Y; Zhao Y; Wang P; Chen Y
    Clin Nucl Med; 2022 Mar; 47(3):246-248. PubMed ID: 34560692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
    Xie F; Fu L; Zhou W
    Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-DOTA-FAPI-04 PET/CT in Erdheim-Chester Disease.
    Wu S; Pang Y; Chen Y; Sun H; Chen H
    Clin Nucl Med; 2021 Mar; 46(3):258-260. PubMed ID: 33417343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of [
    Chen H; Zhao L; Ruan D; Pang Y; Hao B; Dai Y; Wu X; Guo W; Fan C; Wu J; Huang W; Lin Q; Sun L; Wu H
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):73-86. PubMed ID: 32588089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Manifestation of a Patient With Myelofibrosis in 68Ga-DOTA-FAPI-04 PET/CT Mimicking "Super Bone Imaging".
    Li X; Zhao Q; Luo Q; Chen L; Huang Z
    Clin Nucl Med; 2022 Dec; 47(12):1056-1058. PubMed ID: 36342793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.